Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets

Immunology

Volumn 132, Issue 3, 2011, Pages 348-360

  Valentino, Michael D ^a   Maben, Zachary J ^a   Hensley, Lucinda L ^b   Woolard, Matthew D ^b,c   Kawula, Thomas H ^b   Frelinger, Jeffrey A ^b,d   Frelinger, John G ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Epitope discovery; Francisella tularensis; Gateway genomic array; Proteomic array; T lymphocyte

Indexed keywords

EPITOPE; GAMMA INTERFERON; GENOMIC DNA;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; EXPRESSION VECTOR; FRANCISELLA TULARENSIS; GENE DELETION; GENE LIBRARY; IMMUNOASSAY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN PURIFICATION; SEROLOGY; T LYMPHOCYTE;

ANIMALS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FRANCISELLA TULARENSIS; HYBRIDOMAS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; PROTEIN ARRAY ANALYSIS; TULAREMIA;

EID: 79251649416     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03387.x     Document Type: Article

References (88)

1. Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 2007; 1105:1-29.
2. Oyston PC, Sjostedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2004; 2:967-78.
3. Titball RW, Petrosino JF. Francisella tularensis genomics and proteomics. Ann N Y Acad Sci 2007; 1105:98-121.
4. Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect 2003; 5:135-42.
5. Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immunity to Francisella. Ann N Y Acad Sci 2007; 1105:284-324.
6. Rick Lyons C, Wu TH. Animal models of Francisella tularensis infection. Ann N Y Acad Sci 2007; 1105:238-65.
7. Pechous RD, McCarthy TR, Zahrt TC. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev 2009; 73:684-711.
8. Champion MD, Zeng Q, Nix EB et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog 2009; 5:e1000459.
9. Keim P, Johansson A, Wagner DM. Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci 2007; 1105:30-66.
10. Molins CR, Delorey MJ, Yockey BM et al. Virulence differences among Francisella tularensis subsp. tularensis clades in mice. PLoS ONE 2010; 5:e10205.
11. Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, Frelinger JA. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J Immunol 2007; 178:2065-74.
12. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 2007; 178:4538-47.
13. Bosio CM, Dow SW. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol 2005; 175:6792-801.
14. Chase JC, Celli J, Bosio CM. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun 2009; 77:180-95.
15. Bublitz DC, Noah CE, Benach JL, Furie MB. Francisella tularensis suppresses the proinflammatory response of endothelial cells via the endothelial protein C receptor. J Immunol 2010; 185:1124-31.
16. Loegering DJ, Drake JR, Banas JA, McNealy TL, Mc Arthur DG, Webster LM, Lennartz MR. Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. Microb Pathog 2006; 41:218-25.
17. Wilson JE, Katkere B, Drake JR. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect Immun 2009; 77:4953-65.
18. Paranavitana C, Zelazowska E, DaSilva L, Pittman PR, Nikolich M. Th17 cytokines in recall responses against Francisella tularensis in humans. J Interferon Cytokine Res 2010; 30:471-6.
19. Markel G, Bar-Haim E, Zahavy E, Cohen H, Cohen O, Shafferman A, Velan B. The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS ONE 2010; 5:e11176.
20. Woolard MD, Hensley LL, Kawula TH, Frelinger JA. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun 2008; 76:2651-9.
21. + T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun 1994; 62:5603-7.
22. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun 1996; 64:3288-93.
23. Tarnvik A, Ericsson M, Golovliov I, Sandstrom G, Sjostedt A. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microbiol 1996; 13:221-5.
24. Cowley SC, Elkins KL. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med 2003; 198:379-89.
25. - T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med 2005; 202:309-19.
26. - double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. J Immunol 2010; 184:5791-801.
27. + T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 1996; 157:5042-8.
28. Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW. Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev 2008; 225:244-55.
29. Metzger DW, Bakshi CS, Kirimanjeswara G. Mucosal immunopathogenesis of Francisella tularensis. Ann N Y Acad Sci 2007; 1105:266-83.
30. Elkins KL, Bosio CM, Rhinehart-Jones TR. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun 1999; 67:6002-7.
31. Anderson RV, Crane DD, Bosio CM. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine 2010; 28:6562-72.
32. Turner MJ, Abdul-Alim CS, Willis RA, Fisher TL, Lord EM, Frelinger JG. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. J Immunol Methods 2001; 256:107-19.
33. Valentino MD, Hensley LL, Skrombolas D et al. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Mol Immunol 2009; 46:1830-8.
34. Huntley JF, Conley PG, Hagman KE, Norgard MV. Characterization of Francisella tularensis outer membrane proteins. J Bacteriol 2007; 189:561-74.
35. Havlasova J, Hernychova L, Halada P et al. Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2002; 2:857-67.
36. Havlasova J, Hernychova L, Brychta M et al. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 2005; 5:2090-103.
37. Eyles JE, Unal B, Hartley MG et al. Immunodominant Francisella tularensis antigens identified using proteome microarray. Crown Copyright 2007 Dstl. Proteomics 2007; 7:2172-83.
38. Sanderson S, Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 1994; 6:369-76.
39. Gallagher LA, Ramage E, Jacobs MA, Kaul R, Brittnacher M, Manoil C. A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc Natl Acad Sci USA 2007; 104:1009-14.
40. Valentino M, Frelinger J. An approach to the identification of T cell epitopes in the genomic era: application to Francisella tularensis. Immunol Res 2009; 45:218-28.
41. Rock KL, Clark K. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J Immunol 1996; 156:3721-6.
42. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-30.
43. Storozynsky E, Woodward JG, Frelinger JG, Lord EM. Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells. Immunology 1999; 97:138-49.
44. + T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 2008; 28:847-58.
45. Kraemer PS, Mitchell A, Pelletier MR et al. Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice. Infect Immun 2009; 77:232-44.
46. Ahlund MK, Ryden P, Sjostedt A, Stoven S. Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster. Infect Immun 2010; 78:3118-28.
47. Twine SM, Petit MD, Shen H, Mykytczuk NC, Kelly JF, Conlan JW. Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines. Biochem Biophys Res Commun 2006; 346:999-1008.
48. +αβ T cells, but not γδ T cells, to heat shock proteins of Francisella tularensis. Scand J Infect Dis 2001; 33:145-52.
49. Lee BY, Horwitz MA, Clemens DL. Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis. Infect Immun 2006; 74:4002-13.
50. Noah CE, Malik M, Bublitz DC, Camenares D, Sellati TJ, Benach JL, Furie MB. GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect Immun 2010; 78:1797-806.
51. Asea A, Kabingu E, Stevenson MA, Calderwood SK. HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 2000; 5:425-31.
52. Quintana FJ, Cohen IR. Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol 2005; 175:2777-82.
53. Zugel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12:19-39.
54. Nano FE, Schmerk C. The Francisella pathogenicity island. Ann N Y Acad Sci 2007; 1105:122-37.
55. Bonquist L, Lindgren H, Golovliov I, Guina T, Sjostedt A. MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages. Infect Immun 2008; 76:3502-10.
56. Nano FE, Zhang N, Cowley SC et al. A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol 2004; 186:6430-6.
57. Cong Y, Yu JJ, Guentzel MN, Berton MT, Seshu J, Klose KE, Arulanandam BP. Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine 2009; 27:5554-61.
58. Gray CG, Cowley SC, Cheung KK, Nano FE. The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol Lett 2002; 215:53-6.
59. Kadzhaev K, Zingmark C, Golovliov I, Bolanowski M, Shen H, Conlan W, Sjostedt A. Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. PLoS ONE 2009; 4:e5463.
60. Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR. Genome-wide identification of Francisella tularensis virulence determinants. Infect Immun 2007; 75:3089-101.
61. Wehrly TD, Chong A, Virtaneva K et al. Intracellular biology and virulence determinants of Francisella tularensis revealed by transcriptional profiling inside macrophages. Cell Microbiol 2009; 11:1128-50.
62. Broms JE, Lavander M, Sjostedt A. A conserved alpha-helix essential for a type VI secretion-like system of Francisella tularensis. J Bacteriol 2009; 191:2431-46.
63. De Bruin OM, Ludu JS, Nano FE. The Francisella pathogenicity island protein IglA localizes to the bacterial cytoplasm and is needed for intracellular growth. BMC Microbiol 2007; 7:1.
64. Ludu JS, de Bruin OM, Duplantis BN, Schmerk CL, Chou AY, Elkins KL, Nano FE. The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J Bacteriol 2008; 190:4584-95.
65. Mougous JD, Cuff ME, Raunser S et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 2006; 312:1526-30.
66. Pukatzki S, Ma AT, Sturtevant D et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 2006; 103:1528-33.
67. Barker JR, Chong A, Wehrly TD et al. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol Microbiol 2009; 74:1459-70.
68. Barker JR, Klose KE. Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann N Y Acad Sci 2007; 1105:138-59.
69. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11:729-66.
70. Sette A, Grey H, Oseroff C et al. Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 2009; 27(Suppl. 6):G21-6.
71. Assarsson E, Sidney J, Oseroff C et al. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J Immunol 2007; 178:7890-901.
72. Jia Q, Lee BY, Clemens DL, Bowen RA, Horwitz MA. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis. Vaccine 2009; 27:1216-29.
73. Wayne Conlan J, Oyston PC. Vaccines against Francisella tularensis. Ann N Y Acad Sci 2007; 1105:325-50.
74. Sette A, Peters B. Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 2007; 19:106-10.
75. Anthony DD, Lehmann PV. T-cell epitope mapping using the ELISPOT approach. Methods 2003; 29:260-9.
76. Bian H, Reidhaar-Olson JF, Hammer J. The use of bioinformatics for identifying class II-restricted T-cell epitopes. Methods 2003; 29:299-309.
77. Buus S, Claesson MH. Identifying multiple tumor-specific epitopes from large-scale screening for overexpressed mRNA. Curr Opin Immunol 2004; 16:137-42.
78. Gregory SH, Mott S, Phung J et al. Epitope-based vaccination against pneumonic tularemia. Vaccine 2009; 27:5299-306.
79. Hoffmeister B, Kiecker F, Tesfa L, Volk HD, Picker LJ, Kern F. Mapping T cell epitopes by flow cytometry. Methods 2003; 29:270-81.
80. Koelle DM. Expression cloning for the discovery of viral antigens and epitopes recognized by T cells. Methods 2003; 29:213-26.
81. Lemmel C, Stevanovic S. The use of HPLC-MS in T-cell epitope identification. Methods 2003; 29:248-59.
82. Martin W, Sbai H, De Groot AS. Bioinformatics tools for identifying class I-restricted epitopes. Methods 2003; 29:289-98.
83. McMurry JA, Gregory SH, Moise L, Rivera D, Buus S, De Groot AS. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine 2007; 25:3179-91.
84. Reijonen H, Kwok WW. Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 2003; 29:282-8.
85. Sospedra M, Pinilla C, Martin R. Use of combinatorial peptide libraries for T-cell epitope mapping. Methods 2003; 29:236-47.
86. + T cells. Methods 2003; 29:227-35.
87. Nielsen M, Lund O, Buus S, Lundegaard C. MHC Class II epitope predictive algorithms. Immunology 2010; 130:319-28.
88. Boyton RJ, Altmann DM. Transgenic models of autoimmune disease. Clin Exp Immunol 2002; 127:4-11.